Episode #122| The Mini Brain That Learned Pac-Man: NAMs with Dr. Lowry Curley

A brain organoid that can learn to play Pac-Man sounds like a stunt until you realize what it represents: measurable learning, rewiring, and human-relevant neural function that animal models often fail to predict. We talk with Dr. Lowry Curley, founder of Luna LifeSci and former CEO and co-founder of Axosim (now 28 Bio), about why neuroscience drug development breaks so often and how NAMs are finally giving teams better tools to make safer calls earlier.If you’re building in biotech, investing in drug discovery, or just trying to understand what replaces animal testing next, this conversation gives you a clear map of the technology, the incentives, and the milestones to watch. Subscribe, share this with a colleague, and leave a review with the biggest NAM question you want answered next.Show notes: https://3dheals.com/episode-122-new-approach-methodologies-nams-with-dr-lowry-curley/YouTube: https://youtu.be/suVxiYZgPVESend us Fan MailSupport the showSubscribe to our premium version and support the show. Follow us: Twitter  Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D